论文部分内容阅读
目的:介绍德国最新的药物经济学评价方法,为我国提供参考。方法:通过对成本效益评估与效率边界分析的理论阐述与分析,明确其对我国的借鉴意义。结果:成本效益评估与效率边界分析具有一定的优势,同时也带来了一些争议。结论:深入研究德国的成本效益评估与效率边界分析,汲取其中的可取之处将会对完善药物经济学评价方法体系起到积极的推进作用。
Objective: To introduce the latest method of pharmacoeconomic evaluation in Germany and provide reference for our country. Methods: Through the theoretical analysis and interpretation of the cost-benefit assessment and the efficiency boundary analysis, the significance of the reference to our country is clarified. Results: Cost benefit assessment and efficiency boundary analysis have some advantages, but also brought some controversy. CONCLUSIONS: In-depth study of cost-benefit assessment and efficiency boundary analysis in Germany, drawing on the merits, will play a positive role in improving the evaluation system of pharmacoeconomics.